Unproven stem cell therapies: is it my right to try?

CONCLUSIONS: We stress the need, in the age of cellular therapies, for a commitment to support vulnerable patients and to strengthen awareness among the public about the substantial boundary that differentiates experimental therapies from unproven therapies. There should not be a "right to try" something that is unsafe but rather approved treatments and in line with good clinical practice. The trend, which emerged on this issue from our study, is quite different, confirming the urgent need to improve health information so that it is as complete as possible.
PMID: 31264641 [PubMed - in process]

Source: Ann Ist Super Sanita - March 31, 2019 Category: Biomedical Science Authors: Riva L, Campanozzi L, Vitali M, Ricci G, Tambone V Tags: Ann Ist Super Sanita Source Type: research